November 8, 2006
DSM and Crucell Celebrate Opening of PERCIVIA PER.C6® Development Center
in Cambridge, Massachusetts
November 2, 2006
DSM Biologics and UMN Pharma Inc. Sign a Manufacturing Agreement based on the
PER.C6® Manufacturing Platform
October 10, 2006
DSM Biologics and Argenes Inc. Sign A Biopharmaceutical Manufacturing Agreement
September 20, 2006
DSM sells pharmaceutical production site in Michigan (USA) to Albemarle
August 17, 2006
MorphoSys Obtains PER.C6® Human Cell Line for Production of Antibody Material
in MOR103 Program
July 10, 2006
Crucell and DSM Biologics Announce Invitrogen as First Partner in PER.C6®
Vendor Network
May 2, 2006
Integrated Services from DSM Pharmaceutical Products
March 14, 2006
Crucell and DSM Biologics Announce PER.C6® Licensing Agreement with UCB
